Clinical Trial Update: TIP Regimen Combined With Triplizumab Neoadjuvant Therapy for Locally Advanced Penile Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating a TIP regimen combined with Triplizumab as neoadjuvant therapy for locally advanced penile cancer and is currently recrui…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Penile Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• IFOSFAMIDE (IFOSFAMIDE)
• PACLITAXEL (PACLITAXEL)
• Triplizumab (triplizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Penile Cancer | Phase 2 | Status: RECRUITING